Development of a Personalised Care Plan Designed to Reduce Chronic Post-Operative Pain Following Breast Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

154 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-06-30

Study Completion Date

2018-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Numerous surveys have shown that following breast surgery, longterm pain affects around half of patients. Given that 1 in 9 women will get breast cancer and that surgery is the cornerstone of treatment, persistent pain represents a major challenge. In addition to the suffering chronic pain causes to individual patients, the investigators know that it places a substantial burden on families and carers, and that patients with pain represent an excessive demand on healthcare resources.

This research will evaluate the impact of introducing a proactive, integrated care plan for patients having breast surgery. It will assess the effect of the care plan on reducing the number of patients with pain at 3 and 12 months after their procedure.

The personalised plan involves numerous evidence based steps linked by a single unifying description aimed at controlling pain, before, during and after the procedure, in hospital and at home.

Patients at risk of developing pain will be identified prior to the procedure and randomly allocated to follow either the personalised care plan or to receive 'usual' care. In the personalised care plan group, participants will get information about chronic pain, be screened for pain and offered immediate treatment. During their procedure both the surgeon and the anaesthetist will offer treatments such as nerve numbing procedures that reduce the likelihood of experiencing pain.

After their procedure, patients will be again screened for pain and further treatment instigated. Physiotherapists and other allied health professionals such as psychologists will also be involved as appropriate. A package of care for pain will then be passed on to the patients' GP, in the form of a written pain management plan, for ongoing care which will be linked to the hospital. Patients from both groups will be followed up for a year at regular intervals.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Speeding Recovery From Pain and Opioid Use

NCT03388814

Pain, Postoperative Breast Cancer Opioid Use +1 more

WITHDRAWN EARLY_PHASE1

The Effects of Anesthetics on Persistent Pain Following Breast Cancer Surgery

NCT03782896

Breast Cancer Chronic Post-Procedural Pain

COMPLETED

Multimodal Pain Treatment for Breast Cancer Surgery - a Prospective Cohort Study

NCT04875559

Breast Cancer Female Postoperative Pain Postoperative Nausea and Vomiting

COMPLETED

Chronic Pain After Operation for Breast Cancer

NCT00739544

Pain Threshold

UNKNOWN EARLY_PHASE1

Prospectively Assessing Pain After Breast Surgery

NCT05210400

Pain, Postoperative

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Persistent Post-surgical Pain Neuropathic Pain Cancer Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention limb

Medical review and analgesic optimisation.

Pain education (in the form of leaflet and website recommendations)

Psychological input for patients with evidence of psychological morbidity.

Protective analgesia - one pre-procedure dose of 150mg oral pregabalin.

Five days post-procedure oral pregablin twice daily at a dose of 75mg twice a day.

Patients offered a paravertebral block, local anaesthetic infiltrated around the wound by the surgeon.

Daily, focused visits from the hospital pain team.

Any patient displaying concerning pain symptoms, behaviour or who underwent prolonged (\>3 hours surgery) may be booked for early 'preemptive' review in pain clinic.

Group Type ACTIVE_COMPARATOR

Protective analgesia

Intervention Type DRUG

Participants in the intervention arm of the study (if no contraindications exist) will be administered one pre-procedure dose of 150mg of oral pregabalin.

For a total of five days post-procedure the participants in the intervention limb of the study will take oral pregablin twice daily at a dose of 75mg twice a day.

Pain education

Intervention Type OTHER

Participant will receive a pain education leaflet

Psychological support

Intervention Type BEHAVIORAL

Participants demonstrating psychological morbidity will be offered psychological support prior to surgery

Paravertebral block/local anaesthetic infiltration

Intervention Type PROCEDURE

Patients on the intervention limb will be encouraged to have a paravertebral block if not contraindicated

Daily visits from pain team whilst in hospital

Intervention Type OTHER

Usual care

These partcipants will receive usual care before, during and after their breast surgery

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Protective analgesia

Participants in the intervention arm of the study (if no contraindications exist) will be administered one pre-procedure dose of 150mg of oral pregabalin.

For a total of five days post-procedure the participants in the intervention limb of the study will take oral pregablin twice daily at a dose of 75mg twice a day.

Intervention Type DRUG

Pain education

Participant will receive a pain education leaflet

Intervention Type OTHER

Psychological support

Participants demonstrating psychological morbidity will be offered psychological support prior to surgery

Intervention Type BEHAVIORAL

Paravertebral block/local anaesthetic infiltration

Patients on the intervention limb will be encouraged to have a paravertebral block if not contraindicated

Intervention Type PROCEDURE

Daily visits from pain team whilst in hospital

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Pregabalin

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women aged 18 and over with breast cancer undergoing breast surgery at the Royal Marsden Hospital. This includes mastectomy, wide local excision with axillary clearance, breast reconstruction surgery i.e Diep flap, LD flap

Exclusion Criteria

* Previous thoracic surgery.
* Symptomatic angina pectoris.
* Renal impairment.
* Inability to read or to understand consent documentation.
* Patients undergoing the following surgery; lumpectomy, wide local excision, cosmetic procedures, any day-case breast surgery.

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No